Keywords: متابولیسم دارو و فارماکوکینتیک; ADME; absorption distribution metabolism excretion; AFE; average fold error; CLint; intrinsic metabolic clearance; CRO; contract research organisation; CYP; cytochrome P450; DMPK; drug metabolism and pharmacokinetics; G6P; glucose-6-phosphate; t1/2; half-
مقالات ISI متابولیسم دارو و فارماکوکینتیک (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: متابولیسم دارو و فارماکوکینتیک; plasma protein binding; fraction unbound; drug-drug interaction; AUC; area under the curve; AUCR; area under the curve ratio; AAG; alpha 1-acid glycoprotein; CYP; cytochrome P450; BSA; bovine serum albumin; CRO; contract research organization; CV; coeffic
Keywords: متابولیسم دارو و فارماکوکینتیک; ADME-Tox; absorption, distribution, metabolism, excretion, and toxicity; AUC; area under the curve; BnSH; benzyl mercaptan; Xantphos; 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene; CYP2C19; hepatic cytochrome P450 2C19; CYP3A4; hepatic cytochrome P450 3
Keywords: متابولیسم دارو و فارماکوکینتیک; ADME-Tox; absorption, distribution, metabolism, excretion, and toxicity; CYP2C19; hepatic cytochrome P450 2C19; CYP3A4; hepatic cytochrome P450 3A4; DSC; differential scanning calorimetry; DIBAL-H; diisobutylaluminium hydride; DME; 1,2-dimethoxyethane; DM
Keywords: متابولیسم دارو و فارماکوکینتیک; biliary excretion; hepatocytes; ADME; hepatobiliary disposition; cell culture; tissue engineering; toxicology; membrane transport/transporters; disposition; metabolism; 3D; 3-dimensional; 3D-HLT; 3D-bioprinted human liver tissue; APAP; acetaminophen; DMPK
Keywords: متابولیسم دارو و فارماکوکینتیک; Plasmodium falciparum; Malaria; Medicinal chemistry; Phenotypic hit; DMPK; drug metabolism and pharmacokinetics; SAR; structure-activity relationship; WHO; World Health Organisation; WHO-TDR; World Health Organisation Programme for Research and Training i
Keywords: متابولیسم دارو و فارماکوکینتیک; AAT; alpha-1 antitrypsin (alpha-1 proteinase inhibitor, α-1 PI); AATD; alpha-1 antitrypsin deficiency; ALI; acute lung injury; ARDS; acute respiratory distress syndrome; BE; bronchiectasis; CF; cystic fibrosis; COPD; chronic obstructive pulmonary disease
Structure-based design, synthesis, and biological evaluation of imidazo[1,2-b]pyridazine-based p38 MAP kinase inhibitors
Keywords: متابولیسم دارو و فارماکوکینتیک; MAP; mitogen-activated protein; TNF-α; tumor necrosis factor-α; IL-1β; interleukin-1β; RA; rheumatoid arthritis; IBD; inflammatory bowel disease; COPD; chronic obstructive pulmonary disease; LPS; lipopolysaccharide; DMPK; drug metabolism and pharmacok
1,3,5-triazaspiro[5.5]undeca-2,4-dienes as selective Mycobacterium tuberculosis dihydrofolate reductase inhibitors with potent whole cell activity
Keywords: متابولیسم دارو و فارماکوکینتیک; Dihydrofolate reductase (DHFR); Antimycobacterial agent; Tuberculosis (TB); 1,3,5-triazaspiro[5.5]undeca-2,4-diene; DHFR; dihydrofolate reductase; DMPK; drug metabolism and pharmacokinetics; FRLM; female rat liver microsomes; HBA; hydrogen bond acceptors;
In silico toxicity profiling of natural product compound libraries from African flora with anti-malarial and anti-HIV properties
Keywords: متابولیسم دارو و فارماکوکینتیک; 2D; two dimensional; 3D; three dimensional; Afro-HIV; dataset of molecules from African flora with known activities against the human immunodeficiency virus; AfroMalariaDb; dataset of anti-malarial compounds from African flora; DMPK; drug metabolism and p
Targeting Wnt-driven cancers: Discovery of novel tankyrase inhibitors
Keywords: متابولیسم دارو و فارماکوکینتیک; Tankyrase inhibitors; PARP family; Wnt/β-catenin signaling pathway; Wnt pathway disruption; Wnt-driven cancers; APC; adenomatous polyposis coli gene product; ARTD; ADP-ribosyltransferases; CK1; casein kinase 1; DMPK; drug metabolism and pharmacokinetics;
Optimization of a novel series of N-phenylindoline-5-sulfonamide-based acyl CoA:monoacylglycerol acyltransferase-2 inhibitors: Mitigation of CYP3A4 time-dependent inhibition and phototoxic liabilities
Keywords: متابولیسم دارو و فارماکوکینتیک; ACAT; acyl CoA:cholesterol acyltransferase; ADME; absorption, distribution, metabolism and excretion; APCI; atomospheric pressure chemical ionization; CM; chylomicron; dba; dibenzylideneacetone; CYP; cytochrome P450; DDI; drug-drug interaction; DGAT; ac
Coupling ultra-high-pressure liquid chromatography with mass spectrometry for in-vitro drug-metabolism studies
Keywords: متابولیسم دارو و فارماکوکینتیک; ADC; Analog-to-digital converter; ADMET; Absorption, distribution, metabolism, excretion and toxicity; APCI; Atmospheric pressure chemical ionization; CYP; Cytochrome P450; DDI; Drug-drug interaction; DMPK; Drug metabolism and pharmacokinetics; DT; Dwell
Fast mouse PK (Fast PK): A rapid screening method to increase pharmacokinetic throughput in pre-clinical drug discovery
Keywords: متابولیسم دارو و فارماکوکینتیک; PK; pharmacokinetics; PD; pharmacodynamics; PO; per oral; IV; intravenous; HTS; high throughput screening; DMPK; drug metabolism and pharmacokinetics; AUC; area under the curve; HPMC; hydroxypropylmethyl cellulose; CMC; carboxymethyl cellulose; Pharmacoki
High performance liquid chromatography–mass spectrometry analysis for rat metabolism and pharmacokinetic studies of lithospermic acid B from danshen
Keywords: متابولیسم دارو و فارماکوکینتیک; LC–MS; Drug metabolism and pharmacokinetics; Rat; Lithospermic acid B; Danshen